T-EDTA
T-EDTA Limited was established to develop anti-biofilm technologies and infection control products. Anti-biofilm is used in advanced wound care products using the anti-biofilm agents tri sodium/tetra sodium EDTA (‘t-EDTA’). A biofilm is a group of microorganisms in which cells stick to each other and often adhere to a surface, such as wound. As such, they represent a major risk of woundsite infection. EDTA is a chemical which can inhibit the development of such biofilms. Biofilms are a majo... r problem for human infections and medical device related infections due to their becoming resistant to antibiotics, with the result being wounds that are slow to heal, or not healing/remaining open. The patented tri and tetrasodium EDTA (‘T-EDTA’) can be used to prevent and control infection in three specific areas; advanced wound care, catheters and consumer wellness (Skin/foot fungal infections).
T-EDTA
Industry:
Biotechnology Health Care Manufacturing
Founded:
2014-01-01
Address:
Nantwich, Cheshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
0
Investors List
Deepbridge Capital
Deepbridge Capital investment in Venture Round - T-EDTA